Back to results
US 12,305,212 B2Granted
Method for the hydroxylation of steroids
AssigneePharmaZell GmbH
InventorsNicole Staunig, Kai Oliver Donsbach
Life of this patent
Estimating the term…
Abstract
The present invention relates to an enzyme and method for the hydroxylation of a 7-deoxysteroid having the general formula (I) at position 7 to a steroid having the general formula (II)
Claims10
A method of preparing a steroid having the general formula (II):
- wherein
- X1 and X2 are independently H, Cl, F, Br, I, CF3, a C1 to C6 alkyl radical, OH, a C1 to C6 alkoxy radical, CN, NO2, N(R6)2, an epoxy group, CHO, or a CO2R6 radical, wherein
- R6 is —C(O)H, —C(O)CH3, —C(O)CH2CH3, —C(O)(CH2)2CH3, —C(O)CH(CH3)2, —C(O)(CH2)3CH3, —C(O)CH(CH3)CH2CH3, —C(O)CH2CH2(CH3)2, —C(O)C(CH3)3, —C(O)Ph, or —C(O)CH2Ph,
- R1 and R2 are independently H, OH, OR7, or O, wherein
- R7 is —C(O)H, —C(O)CH3, —C(O)CH2CH3, —C(O)(CH2)2CH3, —C(O)CH(CH3)2, —C(O)(CH2)3CH3, —C(O)CH(CH3)CH2CH3, —C(O)CH2CH2(CH3)2, —C(O)C(CH3)3, —C(O)Ph, or —C(O)CH2Ph,
- R3 is H, OH, OR8, a C1 to C10 alkyl radical, a C1 to C10 alkenyl radical, —CHO, —C(O)(CH3), —C(O)(CH2OH), —CH(CH3)C(O)CH3, —CH(CH3)((CH2)2CO2R9), or —CH(CH3)((CH2)2CONHR9), wherein
- R8 is —C(O)H, —C(O)CH3, —C(O)CH2CH3, —C(O)(CH2)2CH3, —C(O)CH(CH3)2, —C(O)(CH2)3CH3, —C(O)CH(CH3)CH2CH3, —C(O)CH2CH2(CH3)2, —C(O)C(CH3)3, —C(O)Ph, or —C(O)CH2Ph, and
- R9 is —CH3, —CH2COOH, —CH2CH3, —CH(CH3)2, —(CH2)2CH3, —(CH2)2SO3H, C(CH3)3, —(CH2)3CH3, —CH(CH3)CH2CH3, —CH2CH2(CH3)2, an aryl group, or an alkylaryl group,
- R4 is H, OH, or —OR10, wherein
- R10 is —C(O)H, —C(O)CH3, —C(O)CH2CH3, —C(O)(CH2)2CH3, —C(O)CH(CH3)2, —C(O)(CH2)3CH3, —C(O)CH(CH3)CH2CH3, —C(O)CH2CH2(CH3)2, —C(O)C(CH3)3, —C(O)Ph, or —C(O)CH2Ph, and
- R5 is H, CF3, a C1 to C6 alkyl radical, a C1 to C6 alkenyl radical, OH, O, or a C1 to C6 alkoxy radical, wherein the dashed line denotes an optional double bond, with the proviso that the B ring has no double bond if the A ring has a C4-C5 double bond, and the C ring has no double bond if X1 and X2 form an epoxy group, or
- wherein the steroid having the general formula (II) is selected from the group consisting of 3α,7β,12α-trihydroxy-5β-cholane-24-acid, 3α,7β,12β-trihydroxy-5β-cholane-24-acid, 3β,7β,12α-trihydroxy-5β-cholane-24-acid, 3β,7β,12β-trihydroxy-5β-cholane-24-acid, 7β,12α-dihydroxy-3-keto-5β-cholane-24-acid, 7β,12β-dihydroxy-3-keto-5β-cholane-24-acid, 3β,7β-dihydroxy-12-keto-5β-cholane-24-acid, 3α,7β-dihydroxy-5β-cholane-24-acid, 7β-hydroxy-3-keto-5β-cholane-24-acid and 3β,7β-dihydroxy-5B-cholane-24-acid,
- the method comprising the step of converting a 7-deoxysteroid selected from the group consisting of 3α,12α-dihydroxy-5β-cholane-24-acid, 3α,12β-dihydroxy-5β-cholane-24-acid, 3β,12α-dihydroxy-5β-cholane-24-acid, 3β,12β-dihydroxy-5β-cholane-24-acid, 3β-hydroxy-12-keto-5β-cholane-24-acid, 3-keto,12β-hydroxy-5β-cholane-24-acid, 3-keto,12α-hydroxy-5β-cholane-24-acid, 3α-hydroxy-5β-cholane-24-acid, 3-keto-5β-cholane-24-acid and 3β-hydroxy-5β-cholane-24-acid or having the general formula (I) with cytochrome P450 enzyme:
- wherein R1-R5 and X1-X2 in formula (I) are as defined in formula (II),
- wherein the cytochrome P450 enzyme comprises an amino acid sequence which has an identity of at least 80% to the amino acid sequence of SEQ ID No. 1 or SEQ ID No. 2.
12 more elements
Dependencies are inferred from the claim text.